Thomas Dietz
Chairman chez EIGER BIOPHARMACEUTICALS, INC.
Fortune : 11 847 $ au 31/03/2024
Profil
Thomas John Dietz is currently the Chairman & Chief Executive Officer at Waypoint Holdings LLC, Chairman at Galleon Pharmaceuticals, Inc., Independent Non-Executive Chairman at Eiger BioPharmaceuticals, Inc., Director at AgBiome INC, Lead Independent Director at Leap Therapeutics, Inc., Director at Nutcracker Therapeutics, Inc., Managing Member at Codfish Investments LLC, and Managing Member at Codpiece Properties LLC.
He has previously worked as the Chief Executive Officer & Director at Pacific Growth Equities, Inc., Independent Director at Virobay, Inc., Independent Director at Eiger BioPharmaceuticals, Inc., Independent Director at Transcept Pharma, Inc., Independent Director at Paratek Pharmaceuticals, Inc., and Head-Investment Banking at Wedbush Securities, Inc. He has also held positions as a Member-Research Faculty at The University of California, San Francisco, a Trustee-West Bay Region at Sutter Health, and a Research Faculty Member at VA Medical Center (District of Columbia).
Dietz holds a doctorate degree from Washington University in St. Louis and an undergraduate degree from State University of New York at Albany.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/11/2023 | 2 367 ( 0,16% ) | 11 847 $ | 31/03/2024 | |
LEAP THERAPEUTICS, INC.
-.--% | 29/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Thomas Dietz
| Sociétés | Poste | Début |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Chairman | 22/03/2016 |
| LEAP THERAPEUTICS, INC. | Director/Board Member | 01/01/2016 |
| Codpiece Properties LLC | Corporate Officer/Principal | 01/05/2012 |
| Codfish Investments LLC | Corporate Officer/Principal | 01/03/2012 |
AgBiome INC
 AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 01/09/2014 |
| Glialogix, Inc. | Director/Board Member | - |
| Waypoint Holdings LLC | Chief Executive Officer | 01/11/2010 |
California Pacific Medical Center
 California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | Director/Board Member | - |
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA. | Chairman | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Thomas Dietz
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░ ░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Thomas Dietz
| Washington University in St. Louis | Doctorate Degree |
| State University of New York at Albany | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| LEAP THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology. | Finance |
Virobay, Inc.
 Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Health Technology |
Galleon Pharmaceuticals, Inc.
Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA. | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
 Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | Health Technology |
California Pacific Medical Center
California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | Commercial Services |
Pacific Growth Equities, Inc.
 Pacific Growth Equities, Inc. Investment Banks/BrokersFinance Pacific Growth Equities, Inc. is a research-driven investment bank located headquartered in San Francisco with an additional office in Boston. The firm specializes in technology-based emerging growth companies. They offer investment banking and brokerage services including public equity offerings, private equity offerings and mergers and acquisitions. Pacific Growth focuses on the life sciences, technology, healthcare and consumer growth companies. | Finance |
Sutter Health
 Sutter Health Medical/Nursing ServicesHealth Services Sutter Health engages in the provision of healthcare services. It offers allergy care, asthma care, gastroenterology, imaging, liver care, occupational health, pediatric, bioethics, dermatology, emergency, back and spine, heart and vascular, cancer, and fertility services. The company was founded in January 1996 and is headquartered in Sacramento, CA. | Health Services |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
| VA Medical Center (District of Columbia) | Government |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | Health Technology |
| Glialogix, Inc. | |
| Waypoint Holdings LLC | |
| Codfish Investments LLC | |
| Codpiece Properties LLC | |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Nutcracker Therapeutics, Inc. provides Biotechnology services. It offers push button operation, rapid cycle times and delivery vehicles. The company was founded by Igor Khandros and Benjamin Eldridge in 2018 and is headquartered in Emeryville, CA. | Technology Services |
